(CLRB) Cellectar Biosciences complete technical analysis [charts+indicators] | Buy/Sell Cellectar Biosciences | (CLRB) share price targets
Complete technical analysis of Cellectar Biosciences (CLRB) by charts plus indicators, forecast predictions and share price targets for Cellectar Biosciences (CLRB)
Cellectar Biosciences trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-20 View latest technical analysis
10 day averaged volume of Cellectar Biosciences is 644650
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 1.56 | 1.61 | 1.69 | 1.55 | 1.154 times |
| 19 Tue Nov 2024 | 1.61 | 1.75 | 1.76 | 1.57 | 2.721 times |
| 18 Mon Nov 2024 | 1.77 | 1.85 | 1.95 | 1.66 | 2.111 times |
| 15 Fri Nov 2024 | 1.86 | 2.01 | 2.04 | 1.83 | 1.887 times |
| 14 Thu Nov 2024 | 2.01 | 2.09 | 2.11 | 1.98 | 0.456 times |
| 13 Wed Nov 2024 | 2.09 | 2.14 | 2.18 | 2.06 | 0.424 times |
| 12 Tue Nov 2024 | 2.14 | 2.11 | 2.15 | 2.09 | 0.319 times |
| 11 Mon Nov 2024 | 2.12 | 2.16 | 2.20 | 2.08 | 0.504 times |
| 08 Fri Nov 2024 | 2.12 | 2.11 | 2.13 | 2.06 | 0.312 times |
| 07 Thu Nov 2024 | 2.11 | 2.06 | 2.16 | 2.01 | 0.857 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 1.6, for a target of 1.8 or 1.99
Share price targets for Cellectar Biosciences (CLRB)
| Target Type | Value |
| Downside Target | 1.55 |
| Upside Target | 1.82 |
| Upside Target | 1.90 |
| Upside Target | 1.95 |
| Upside Target | 2.13 |
| Upside Target | 2.16 |
| Upside Target | 2.20 |
| Upside Target | 2.24 |
| Upside Target | 2.25 |
| Upside Target | 2.29 |
| Upside Target | 3.15 |
Intraday share price targets for Cellectar Biosciences (CLRB)
| Target Type | Value |
| Downside Intraday Target | 1.42 |
| Downside Intraday Target | 1.29 |
| Upside Intraday Target | 1.82 |
| Upside Intraday Target | 2.09 |
| Upside Intraday Target | 1.69 |
Weekly technical analysis of Cellectar Biosciences (CLRB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 1.56 | 1.85 | 1.95 | 1.55 | 1.667 times |
| 15 Fri Nov 2024 | 1.86 | 2.16 | 2.20 | 1.83 | 1.801 times |
| 08 Fri Nov 2024 | 2.12 | 2.03 | 2.16 | 2.00 | 1.263 times |
| 01 Fri Nov 2024 | 2.03 | 2.03 | 2.13 | 1.97 | 0.875 times |
| 25 Fri Oct 2024 | 2.03 | 2.11 | 2.15 | 2.01 | 1.088 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Cellectar Biosciences (CLRB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 1.56 | 1.98 | 2.20 | 1.55 | 1.517 times |
| 31 Thu Oct 2024 | 2.04 | 2.13 | 2.25 | 1.97 | 1.036 times |
| 30 Mon Sep 2024 | 2.14 | 2.17 | 2.24 | 1.90 | 0.575 times |
| 30 Fri Aug 2024 | 2.20 | 2.15 | 2.29 | 1.82 | 0.459 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Cellectar Biosciences (CLRB)
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cellectar Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Cellectar Biosciences in short term and the sell signal is strong.
Cellectar Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cellectar Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cellectar Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.81 and Cellectar Biosciences (CLRB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cellectar Biosciences (CLRB) stock. Volume based technical analysis of Cellectar Biosciences (CLRB) stock is negative.
Cellectar Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cellectar Biosciences ( (CLRB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cellectar Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Cellectar Biosciences in short term and the sell signal is strong.
Cellectar Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cellectar Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cellectar Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.81 and Cellectar Biosciences (CLRB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cellectar Biosciences (CLRB) stock. Volume based technical analysis of Cellectar Biosciences (CLRB) stock is negative.
Cellectar Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.